Insulin resistance and excess risk of diabetes in Mexican-Americans: The San Antonio heart study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages 793-799

  Lorenzo, Carlos ^a   Hazuda, Helen P ^a   Haffner, Steven M ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CAUCASIAN; COMPUTER PROGRAM; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INCIDENCE; INSULIN RELEASE; INSULIN RESISTANCE; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATSUDA INDEX; METABOLIC PARAMETERS; POPULATION RESEARCH; POPULATION RISK; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; UNITED STATES;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MEXICAN AMERICANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK; RISK FACTORS;

EID: 84858017105     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2272     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention 2011 National Diabetes Fact Sheet. Available from http://www.cdc.gov/diabetes/pubs/factsheet11.htm. Accessed 7 March 2011
2. American Diabetes Association 2008 Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596-615
3. Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP 1991 Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 14:102-108
4. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M 2000 Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283: 2253-2259 (Pubitemid 30246776)
5. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD; Diabetes Epidemiology Study Group in India (DESI) 2001 High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44:1094-1101 (Pubitemid 32835500)
6. Knowler WC, Bennett PH, Hamman RF, Miller M 1978 Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505 (Pubitemid 9147733)
7. Egede LE, Dagogo-Jack S 2005 Epidemiology of type 2 diabetes: focus on ethnic minorities. Med Clin North Am 89:949-975, viii (Pubitemid 41208274)
8. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH 1991 A two-step model for development of non-insulin-dependent diabetes. Am J Med 90:229-235
9. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR 1992 Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow up study. Lancet 340:925-929
10. Haffner SM, Miettinen H, Gaskill SP, Stern MP 1995 Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386-1391
11. Lorenzo C, Wagenknecht LE, D'Agostino Jr RB, Rewers MJ, Karter AJ, Haffner SM 2010 Insulin resistance, β-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study. Diabetes Care 33:67-72
12. Osei K, Rhinesmith S, Gaillard T, Schuster D 2004 Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African-Americans: implications for primary diabetes prevention. Diabetes Care 27:1439-1446 (Pubitemid 38679995)
13. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN 1996 Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45:742-748
14. Lillioja S, Nyomba BL, Saad MF, Ferraro R, Castillo C, Bennett PH, Bogardus C 1991 Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73:866-876 (Pubitemid 21921951)
15. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK 1986 Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med 315:220-224 (Pubitemid 16097123)
16. Osei K, Schuster DP, Owusu SK, Amoah AG 1997 Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African ancestry and white Americans. Metabolism 46:53-58 (Pubitemid 27052024)
17. Boyko EJ, Keane EM, Marshall JA, Hamman RF 1991 Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM: San Luis Valley Diabetes Study. Diabetes 40:509-515
18. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J 1995 Pancreatic β-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855-1861
19. Haffner SM, Miettinen H, Stern MP 1996 Nondiabetic Mexican- Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites. Diabetes Care 19:67-69 (Pubitemid 26006619)
20. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte Jr D 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672 (Pubitemid 23318125)
21. Bergman RN, Finegood DT, Kahn SE 2002 The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32(Suppl 3):35-45 (Pubitemid 41704998)
22. Festa A, Williams K, D'Agostino Jr R, Wagenknecht LE, Haffner SM 2006 The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55:1114-1120 (Pubitemid 44100189)
23. Hanley AJ, Williams K, Gonzalez C, D'Agostino Jr RB, Wagenknecht LE, Stern MP, Haffner SM 2003 Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52:463-469 (Pubitemid 36173204)
24. Festa A, Williams K, Hanley AJ, Haffner SM 2008 β-Cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 57: 1638-1644
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
26. Wallace TM, Levy JC, Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495 (Pubitemid 38680001)
27. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
28. Lorenzo C, Haffner SM, Stancáková A, Laakso M 2010 Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic Finnish offspring of type 2 diabetic individuals. J Clin Endocrinol Metab 95:5082-5090
29. Seltzer HS, Allen EW, Herron Jr AL, Brennan MT 1967 Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323-335
30. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA 2004 β-Cell dysfunction and glucose intolerance: results from the San Antonio Metabolism (SAM) Study. Diabetologia 47:31-39 (Pubitemid 38141937)
31. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F, Kosaka K 1984 Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26:44-49 (Pubitemid 14182349)
32. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP 1999 Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med 159:1450-1456 (Pubitemid 29302885)
33. Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M 2009 Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58:1212-1221
34. Phillips DI, Clark PM, Hales CN, Osmond C 1994 Understanding oral glucose tolerance: comparison of glucose and insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and secretion. Diabet Med 11:286-292 (Pubitemid 24144145)
35. Steiger JH 1980 Tests for comparing elements of a correlation matrix. Psychol Bull 87:245-251
36. DeLong ER, DeLong DM, Clarke-Pearson DL 1988 Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845
37. van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW 1998 Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects: assessments using hyperglycemic glucose clamp and oral glucose tolerance tests. Diabetes Care 21:278-282